<DOC>
	<DOC>NCT01720537</DOC>
	<brief_summary>This study is to evaluate the safety, tolerability and immunogenicity of single, ascending or multiple fixed subcutaneous and intravenous administrations of PF 05335810 to hypercholesterolemic subjects when added on to a daily statin dose.</brief_summary>
	<brief_title>A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>On stable daily doses of a statin for 45 days prior to receiving study treatment. Fasting LDL C equal or greater than 80 mg/dL at screening and visit approximately 1 week prior to randomization. History of a cardiovascular or cerebrovascular event or procedure within one year of randomization. Poorly controlled type 1 or type 2 diabetes mellitus (defined as HbA1c &gt;9%).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>High Cholesterol</keyword>
	<keyword>Dyslipidemia</keyword>
</DOC>